Overview

* IDEX ( IEX ) Q2 sales rise 7% yr/yr to $865 mln, beating analyst expectations

* Adjusted EPS for Q2 exceeds analyst expectations, per LSEG data

Outlook

* IDEX ( IEX ) revises full-year EPS to $6.30-$6.44 GAAP, $7.85-$7.95 adjusted

* Company expects Q3 2025 GAAP EPS of $1.54-$1.61

* IDEX ( IEX ) sees Q3 organic sales growth of 2%-3%

* Company anticipates full-year organic sales growth of 1%

Result Drivers

* MOTT ACQUISITION - Sales increase driven by Mott acquisition and positive pricing strategies

* VOLUME DELEVERAGE - Gross margin affected by unfavorable mix and volume deleverage, partially offset by productivity improvements

* INTEREST EXPENSE - Higher interest expense due to debt from Mott acquisition impacted EPS

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q2 Sales Beat $865.40 $858.70

mln mln (9

Analysts

)

Q2 Beat $2.07 $1.99 (9

Adjusted Analysts

EPS )

Q2 EPS $1.74

Q2 Beat $156.50 $151 mln

Adjusted mln (6

Net Analysts

Income )

Q2 Beat $237.20 $209.90

Adjusted mln mln (2

EBITDA Analysts

)

Q2 45.3%

Adjusted

Gross

Margin

Analyst Coverage

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 8 "strong buy" or "buy", 7 "hold" and no "sell" or "strong sell"

* The average consensus recommendation for the industrial machinery & equipment peer group is "buy"

* Wall Street's median 12-month price target for IDEX Corp ( IEX ) is $215.50, about 14.1% above its July 29 closing price of $185.18

* The stock recently traded at 22 times the next 12-month earnings vs. a P/E of 21 three months ago

Press Release:

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)